Yukihiro Kitai
Yukihiro Kitai has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Satori Hirai
Department of Pediatric Neurology, Bobath Memorial Hospital, Osaka, Japan
6 shared publications- Hiroshi Arai
Department of Pediatric Neurology, Bobath Memorial Hospital, Osaka, Japan
5 shared publications Hiroshi Arai
Department of Pediatric Neurology, Bobath Memorial Hospital, Osaka, Japan
4 shared publicationsKayo Ohmura
Department of Pediatrics, Shimoshizu National Hospital, Yotsukaido, Japan
4 shared publicationsMika Hirotsune
Department of Pediatric Neurology, Bobath Memorial Hospital, Osaka, Japan
4 shared publicationsKaeko Ogura
Division of Child and Adolescent Mental Health, Department of Psychosocial Medicine, National Center for Child Health and Development, Setagaya-ku, Japan
3 shared publications
Latest Publications
- 11 August 2026
- Published by Wiley in Clinical Genetics
- Vol. 110 (5) , 616-621
Two Japanese Cases Highlighting Structural and Phenotypic Overlap in AGO1 ‐ and AGO2 ‐Related Neurodevelopmental Disorders
Pathogenic variants in AGO1 and AGO2, core components of the Argonaute family, have emerged as causes of rare neurodevelopmental disorders characterized by intellectual disability, marked language impairment, behavioral abnormalities, and distinctive craniofacial features. Reported variants cluster at the L1–PAZ boundary, a structurally sensitive region essential for guide‐RNA engagement. We describe two unrelated Japanese individuals carrying de novo variants in AGO1 (NM_012199.5):c.569T>C p.(Leu190Pro) or AGO2 (NM_012154.6):c.544_546del p.(Phe182del), affecting structurally corresponding residues within this boundary. Both individuals exhibited global developmental delay, hypotonia, midface hypoplasia, thin upper lip, elongated facial shape, and reduced cerebral white matter volume, aligning with previously reported AGO1‐ and AGO2‐related phenotypes. Structural assessment using AlphaFold2‐based AGO1 models and the AGO2 crystal structure confirmed positional equivalence of the affected residues, supporting the concept of a shared structural vulnerability across Argonaute paralogs. These observations expand the phenotypic spectrum of Argonaute‐related neurodevelopmental disorders in the Japanese population and highlight RNA‐regulatory dysfunction as a coherent pathogenic axis. Recognition of this clinical gestalt may assist clinicians in prioritizing AGO1 and AGO2 during genomic evaluation of unexplained neurodevelopmental disorders.
- 11 August 2026
- Published by Wiley in Clinical Genetics
- Vol. 110 (5) , 616-621
Two Japanese Cases Highlighting Structural and Phenotypic Overlap in AGO1 ‐ and AGO2 ‐Related Neurodevelopmental Disorders
Pathogenic variants in AGO1 and AGO2, core components of the Argonaute family, have emerged as causes of rare neurodevelopmental disorders characterized by intellectual disability, marked language impairment, behavioral abnormalities, and distinctive craniofacial features. Reported variants cluster at the L1–PAZ boundary, a structurally sensitive region essential for guide‐RNA engagement. We describe two unrelated Japanese individuals carrying de novo variants in AGO1 (NM_012199.5):c.569T>C p.(Leu190Pro) or AGO2 (NM_012154.6):c.544_546del p.(Phe182del), affecting structurally corresponding residues within this boundary. Both individuals exhibited global developmental delay, hypotonia, midface hypoplasia, thin upper lip, elongated facial shape, and reduced cerebral white matter volume, aligning with previously reported AGO1‐ and AGO2‐related phenotypes. Structural assessment using AlphaFold2‐based AGO1 models and the AGO2 crystal structure confirmed positional equivalence of the affected residues, supporting the concept of a shared structural vulnerability across Argonaute paralogs. These observations expand the phenotypic spectrum of Argonaute‐related neurodevelopmental disorders in the Japanese population and highlight RNA‐regulatory dysfunction as a coherent pathogenic axis. Recognition of this clinical gestalt may assist clinicians in prioritizing AGO1 and AGO2 during genomic evaluation of unexplained neurodevelopmental disorders.
- 7 September 2023
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 47, 41-46
Childhood-onset epilepsy in patients with dyskinetic cerebral palsy caused by basal ganglia and thalamic lesions
- 7 September 2023
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 47, 41-46
Childhood-onset epilepsy in patients with dyskinetic cerebral palsy caused by basal ganglia and thalamic lesions
- 1 August 2021
- Published by Elsevier in Pediatric Neurology
- Vol. 121, 56-58
Magnetic Resonance Imaging Findings in Preterm Infants With Bilirubin Encephalopathy Beyond Three Years Corrected Age
- 1 August 2021
- Published by Elsevier in Pediatric Neurology
- Vol. 121, 56-58
Magnetic Resonance Imaging Findings in Preterm Infants With Bilirubin Encephalopathy Beyond Three Years Corrected Age
- 1 March 2021
- Published by Elsevier in Early Human Development
- Vol. 154, 105319
Auditory brainstem response in preterm infants with bilirubin encephalopathy
- 1 March 2021
- Published by Elsevier in Early Human Development
- Vol. 154, 105319
Auditory brainstem response in preterm infants with bilirubin encephalopathy
- 1 January 2021
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 30, 108-112
Functional outcomes of children with dyskinetic cerebral palsy depend on etiology and gestational age
- 1 January 2021
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 30, 108-112
Functional outcomes of children with dyskinetic cerebral palsy depend on etiology and gestational age
- 1 April 2020
- Published by Elsevier in Brain and Development
- Vol. 42 (4) , 322-328
A questionnaire survey on the efficacy of various treatments for dyskinetic cerebral palsy due to preterm bilirubin encephalopathy
- 1 April 2020
- Published by Elsevier in Brain and Development
- Vol. 42 (4) , 322-328
A questionnaire survey on the efficacy of various treatments for dyskinetic cerebral palsy due to preterm bilirubin encephalopathy
- 4 October 2019
- Published by S. Karger AG in Neonatology
- Vol. 117 (1) , 73-79
Diagnosis of Bilirubin Encephalopathy in Preterm Infants with Dyskinetic Cerebral Palsy
Introduction: Very preterm infants are susceptible to bilirubin neurotoxicity, the signs of which are unclear during early infancy. We investigated children born preterm and later diagnosed with bilirubin encephalopathy (BE) to gain insights into accurate early diagnosis. Methods: We identified 93 children born preterm and clinically diagnosed with BE who visited our hospital between 2006 and 2018. Perinatal history, findings of auditory brainstem response (ABR), brain magnetic resonance imaging (MRI), and functional outcomes were investigated retrospectively based on chart review. Results: The mean gestational age and birth weights were 27.2 weeks and 991 g, respectively. During the neonatal period, only 3% (2/71) had exchange transfusions, and none were diagnosed with acute BE. ABR was abnormal in 64% (51/80), but the majority (34/51) required no hearing aids. Brain MRI taken between 6 and 18 months of age revealed bilateral T2 hyperintensity of the globi pallidi in 91% (60/66); subsequently, the rate decreased with age. Functional communication outcomes were markedly superior to gross motor and hand function outcomes. Conclusion: For early diagnosis of BE, brain MRI is recommended at a corrected age of between 6 and 18 months, especially for those with abnormal ABR during early infancy, and even with no apparent history of marked neonatal hyperbilirubinemia.
- 4 October 2019
- Published by S. Karger AG in Neonatology
- Vol. 117 (1) , 73-79
Diagnosis of Bilirubin Encephalopathy in Preterm Infants with Dyskinetic Cerebral Palsy
Introduction: Very preterm infants are susceptible to bilirubin neurotoxicity, the signs of which are unclear during early infancy. We investigated children born preterm and later diagnosed with bilirubin encephalopathy (BE) to gain insights into accurate early diagnosis. Methods: We identified 93 children born preterm and clinically diagnosed with BE who visited our hospital between 2006 and 2018. Perinatal history, findings of auditory brainstem response (ABR), brain magnetic resonance imaging (MRI), and functional outcomes were investigated retrospectively based on chart review. Results: The mean gestational age and birth weights were 27.2 weeks and 991 g, respectively. During the neonatal period, only 3% (2/71) had exchange transfusions, and none were diagnosed with acute BE. ABR was abnormal in 64% (51/80), but the majority (34/51) required no hearing aids. Brain MRI taken between 6 and 18 months of age revealed bilateral T2 hyperintensity of the globi pallidi in 91% (60/66); subsequently, the rate decreased with age. Functional communication outcomes were markedly superior to gross motor and hand function outcomes. Conclusion: For early diagnosis of BE, brain MRI is recommended at a corrected age of between 6 and 18 months, especially for those with abnormal ABR during early infancy, and even with no apparent history of marked neonatal hyperbilirubinemia.
- 1 March 2016
- Published by Elsevier in Brain and Development
- Vol. 38 (3) , 267-273
Outcome of hemiplegic cerebral palsy born at term depends on its etiology
- 1 March 2016
- Published by Elsevier in Brain and Development
- Vol. 38 (3) , 267-273
Outcome of hemiplegic cerebral palsy born at term depends on its etiology
- 1 September 2015
- Published by Elsevier in Brain and Development
- Vol. 37 (8) , 758-763
Cerebellar injury in preterm children with cerebral palsy after intraventricular hemorrhage: Prevalence and relationship to functional outcomes
- 1 September 2015
- Published by Elsevier in Brain and Development
- Vol. 37 (8) , 758-763
Cerebellar injury in preterm children with cerebral palsy after intraventricular hemorrhage: Prevalence and relationship to functional outcomes
- 1 January 2015
- Vol. 47 (1) , 43-8
[Long-term outcome of childhood hypoxic-ischemic encephalopathy].
To propose an adequate rehabilitation program for children suffering from hypoxic-ischemic encephalopathy (HIE) based on estimated outcomes. Participants were 42 children, 28 boys and 14 girls, who suffered from HIE after neonatal period. We divided them into three groups; favorable (GMFCS level 1 or 2), moderate (level 3 or 4), and unfavorable (level 5), and compared the extent of brain lesions on MRI, age of onset, and complications among the groups. The number of children in favorable, moderate, and unfavorable groups was 10, 10 and 22, respectively. All children in favorable and moderate groups showed focal cerebral lesions on MRI. In contrast, most children in unfavorable group (19/22) had diffuse brain damage and the rest were infantile onset with focal cerebral lesions. The etiology and situation of HIE did not differ among three groups. Three children in moderate group whose onsets were earlier than 5 months showed lesions similar to those in neonatal HIE; in bilateral basal ganglia, thalamus, and perirolandic cortex. In favorable group, 7 children were able to walk independently within 5 months after the insult, but 9 had moderate or severe mental retardation and 3 showed severe visual impairment. A majority of unfavorable group developed scoliosis or hip dislocation, and underwent tracheostomy or gastrostomy. Five children who had stayed acute hospitals for longer than 6 months developed irreversible complications such as joint contractures before discharge. Children with focal cerebral lesions need continual rehabilitation and education for mental retardation and visual impairment, even if they can walk within several months after HIE. Those with diffuse brain damage need sufficient rehabilitation as early as possible to avoid developing secondary complications. MR image, age of onset, and clinical course were of great prognostic value to make appropriate long-term rehabilitation and education programs.
- 1 January 2015
- Vol. 47 (1) , 43-8
[Long-term outcome of childhood hypoxic-ischemic encephalopathy].
To propose an adequate rehabilitation program for children suffering from hypoxic-ischemic encephalopathy (HIE) based on estimated outcomes. Participants were 42 children, 28 boys and 14 girls, who suffered from HIE after neonatal period. We divided them into three groups; favorable (GMFCS level 1 or 2), moderate (level 3 or 4), and unfavorable (level 5), and compared the extent of brain lesions on MRI, age of onset, and complications among the groups. The number of children in favorable, moderate, and unfavorable groups was 10, 10 and 22, respectively. All children in favorable and moderate groups showed focal cerebral lesions on MRI. In contrast, most children in unfavorable group (19/22) had diffuse brain damage and the rest were infantile onset with focal cerebral lesions. The etiology and situation of HIE did not differ among three groups. Three children in moderate group whose onsets were earlier than 5 months showed lesions similar to those in neonatal HIE; in bilateral basal ganglia, thalamus, and perirolandic cortex. In favorable group, 7 children were able to walk independently within 5 months after the insult, but 9 had moderate or severe mental retardation and 3 showed severe visual impairment. A majority of unfavorable group developed scoliosis or hip dislocation, and underwent tracheostomy or gastrostomy. Five children who had stayed acute hospitals for longer than 6 months developed irreversible complications such as joint contractures before discharge. Children with focal cerebral lesions need continual rehabilitation and education for mental retardation and visual impairment, even if they can walk within several months after HIE. Those with diffuse brain damage need sufficient rehabilitation as early as possible to avoid developing secondary complications. MR image, age of onset, and clinical course were of great prognostic value to make appropriate long-term rehabilitation and education programs.